Givaudan SA
Givaudan sells flavours and fragrances to whoever makes the finished product. Symrise and dsm-firmenich compete for the same formula. It is not the world leader by decree. This report does not list perfume houses or food companies as if they were exclusive contracts, and it does not state a retention rate.
The formula already on the market is hard to touch, and it gets touched. The customer can reformulate, split the volume or drop the product. A good year for the brand is not Givaudan's normal earnings. The secrecy of the formula lasts while the customer does not replace it.
The dividend comes from that cash. It has to fit. It is not a sensory patent.
"The advantage is the formula already approved in the customer's product and the history of work with their team. The customer can open the formula to someone else. The moat narrows if they reformulate, or if the finished product sells less."
Loading the Vaultflake…
—
Health is debt against an ingredients business, not against the brand on the shelf. Quality is the formula margin. Growth follows launches and the customer's volume. P/E is read against a year of many launches, not against that year as normal. Shareholder return is the dividend, checked against cash. Do not read it as near-perfect retention.
The P/E of a year of many launches is not normal earnings. EV/EBITDA is read without treating the formula's secrecy as if another supplier could not take the slot. Do not use Symrise's multiple as if the mix of food and perfume were the same. A dash if the GIVN.SW cache is cold.
Not advice on Givaudan. Vaultflake does not count customers and does not treat the formula as irreplaceable. This is not near-perfect retention. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
The advantage is the formula already approved in the customer's product and the history of work with their team. The customer can open the formula to someone else. The moat narrows if they reformulate, or if the finished product sells less.
Health is debt against an ingredients business, not against the brand on the shelf. Quality is the formula margin. Growth follows launches and the customer's volume. P/E is read against a year of many launches, not against that year as normal. Shareholder return is the dividend, checked against cash. Do not read it as near-perfect retention.
The P/E of a year of many launches is not normal earnings. EV/EBITDA is read without treating the formula's secrecy as if another supplier could not take the slot. Do not use Symrise's multiple as if the mix of food and perfume were the same. A dash if the GIVN.SW cache is cold.
Not advice on Givaudan. Vaultflake does not count customers and does not treat the formula as irreplaceable. This is not near-perfect retention. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Materials · Industrial Gases
Materials · Industrial Gases
Materials · Chemicals
Materials · Mining
Materials · Stainless Steel
Materials · Architectural Paint
A free account opens the interactive chart. The Vault assistant is Premium.